Mind-Body Interventions in Coronary Artery Disease
ConditionCoronary Artery Disease (CAD)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
Sponsorşeyda candeniz
About this trial
This randomized controlled study aims to evaluate the effects of a combined mind-body intervention consisting of progressive muscle relaxation and guided imagery on psychological outcomes in patients with stable coronary artery disease.
A total of 40 participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive eight individualized sessions over four weeks in addition to standard medical care, while the control group will continue with standard care only.
Primary and secondary outcomes will be assessed using validated self-report instruments, including the Perceived Stress Scale (PSS), Hospital Anxiety and Depression Scale (HADS), and COPE Inventory, administered at baseline and after the intervention period.
The main objective of the study is to determine whether structured mind-body techniques can reduce perceived stress, anxiety, and depressive symptoms and improve coping strategies in patients with coronary artery disease.
Eligibility criteria
Qualifiers
Diagnosed with stable coronary artery disease
Aged between 18 and 65 years
Able to read and understand Turkish
Able to complete study questionnaires and assessments
Disqualifiers
History of acute coronary syndrome within the last 3 months
Presence of a diagnosed severe psychiatric disorder
Cognitive impairment or communication difficulties that may interfere with study participation
Previous regular participation in mind-body interventions such as progressive muscle relaxation, guided imagery, meditation, or similar programs
Trial design
Treatments tested in this trial
- Progressive Muscle Relaxation and Guided Imagery
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
şeyda candeniz
Lead sponsor
Ankara University
Sponsor institution
Source ClinicalTrials.gov